TIMSA company recognized the children of its collaborators who obtained the best averages in the previous school year, in elementary and middle school. It was a drive-by event with all the prevention measures, the winning children received their recognition and participated in the raffle for laptops and gift certificates for school supplies.
The President of Fundación Index Mexicali, Víctor Hugo Delgado Sánchez, received from the General Manager of Sensata, Genaro González Velásquez, the donation of 10 oximeters and ten gallons of sanitizer. Which will be delivered to children’s homes and nursing homes as part of the campaign “Protecting our future.” The delivery was also attended by the Operations Manager of the plant Fernando Preza Lagunes and the Operating Director of Index Mexicali René Marín Rivas. You can still support by donating sanitizing products, face masks, protective glasses, oximeters and/or digital thermometers.
Mexicali, Baja California- As part of its great commitment to the citizens of its state and city, Martech Medical, in a coordinated effort with INDEX Mexicali, the State Secretary of Economy and Tourism and the organization ApoyemosMexicali, has authorized a donation of medical devices to the Health Ministry of Baja California with an approximate value of $3.5 million pesos. The objective of this donation is to contribute to the care and protection of patients as well as medical equipment facing the COVID-19 pandemic.
During the delivery that took place on April 9, 2020, at the facilities of the Health Ministry in Mexicali, Anabel Valle, Martech’s General Manager reiterated the company’s commitment to society and thanked the great work of the medical staff in the city.
“Martech Medical Products is committed to the community and its collaborators, and through this donation, we contribute to the work of health institutions to mitigate the effects of the pandemic. We greatly appreciate the efforts of the medical staff who are dealing directly with the potential source of the virus on a daily basis. We respect and value their work. In these times, it is our main purpose to strictly adhere to prevention measures and continue to manufacture critical products that the health system needs to treat the disease, to support its strenuous and essential task. I reiterate our commitment to continue to focus on our common goal. Thank you very much.”, mentioned Martech´s General Manager.
Among the items donated were: Peritoneal dialysis kits, short-term dialysis catheters, ports for patients with cancer or long-term infusion needs, some peripherally inserted intensive care venous catheters, and others.
They were present at the delivery, Gabriel Cabañas, General Coordinator of Promotion at the Secretary of Sustainable Economy and Tourism of Baja California, Dr. Sandra Martínez Lobatos, Director of Health Services, Carlos Gómez, Deputy General Director of Administration ISESALUD, Victor Hugo Delgado, President Index Mexicali, Rene Marín, Operating Director Index Mexicali, Anabel Valle, General Manager of Martech Medical and Alfonso Verdugo, Human Resources Manager of Martech Medical, as well as Marco Kuljacha, VP of Grupo Prodensa and Sergio Vindiola, Senior Project Manager of Prodensa, the company that supported the start-up of the company in the city.
Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours. The test for COVID-19 can help medical facilities make fast diagnoses and play a part in containing the coronavirus pandemic.
The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help medical facilities such as doctors’ offices, hospitals, laboratories, and health centers make fast diagnoses.
The rapid molecular diagnostic test runs on the Vivalytic analysis device from Bosch Healthcare Solutions. “We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up the identification and isolation of infected patients,” says Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH.
Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours — measured from the time the sample is taken to the time the result arrives. Another advantage of the rapid test is that it can be performed directly at the point of care. This eliminates the need to transport samples, which takes up valuable time. It also means patients quickly gain certainty about their state of health, while allowing infected individuals to be identified and isolated immediately. With the tests currently in use, patients must usually wait one to two days for a result. “Time is of the essence in the fight against coronavirus. Reliable, rapid diagnosis directly on site with no back and forth — that is the great advantage of our solution, which we see as another example of technology that is ‘Invented for life,’” Denner says.
Bosch’s rapid test is one of the world’s first fully automated molecular diagnostic tests that can be used directly by all medical institutions. What’s more, it allows a single sample to be tested not just for COVID-19 but also for nine other respiratory diseases, including influenza A and B, simultaneously. “The special feature of the Bosch test is that it offers differential diagnosis, which saves doctors the additional time needed for further tests. It also provides them with a reliable diagnosis quickly so they can then begin suitable treatment faster,” says Marc Meier, president of Bosch Healthcare Solutions GmbH. The newly developed test will be available in Germany starting in April, with other markets in Europe and elsewhere to follow.
Bosch’s rapid COVID-19 test is the result of collaboration between the company’s Bosch Healthcare Solutions subsidiary and the Northern Irish medical technology company Randox Laboratories Ltd. “Together with our partner Randox, we have succeeded in developing this innovative rapid test within a very short time frame, and we are now in a position to offer it to the market. The Bosch Vivalytic analysis device evaluates the test safely and reliably directly in the hospital, in the lab, or in the doctor’s office, guaranteeing the best possible protection for patients and medical staff,” Meier says. The company is currently examining how it can help doctors and nursing staff in medical facilities such as the Robert Bosch Hospital get tested promptly so they can be fit to work for as long as possible — with no risk of infecting others.
Up to 1,000 tests per day on just 100 devices.
Easy application at the point of care
In various laboratory tests with SARS-CoV-2, the Bosch test delivered results with an accuracy of over 95 percent. The rapid test meets the quality standards of the World Health Organization (WHO). A sample is taken from the patient’s nose or throat using a swab. Then the cartridge, which already contains all the reagents required for the test, is inserted into the Vivalytic device for analysis. During the analysis, medical staff can devote themselves to other tasks, for example treating patients. The Vivalytic analyzer is designed to be so user-friendly that even medical personnel who have not been specially trained on it can reliably perform the test.
A Bosch Vivalytic analyzer can perform up to ten tests in the space of 24 hours. This means it takes just 100 devices to evaluate up to 1,000 tests per day. Given the dynamic spread of the coronavirus SARS-CoV-2, laboratories are already working beyond capacity. The Bosch Vivalytic will thus help to increase available testing capacities.
Copyright by PIMSA 2019. All rights reserved.
Copyright by PIMSA 2019. All rights reserved.